Looking for a specific product?

Make a search for products & suppliers, articles & news.

Collaboration across the pond develops a new living skin equivalent testing model

Epistem and ScandiDerma announced today that they aim to develop a new in vitro human living skin equivalent model for testing inflammatory responses.

Facts

Innovation Norway is the Norwegian Government's most important instrument for innovation and development of Norwegian enterprises and industry. Innovation Norway support companies in developing their competitive advantage and to enhance innovation. Norwegian enterprises have access to a broad business support system as well as financial means. By combining local industry knowledge and international networks with the business ideas and the motivation of entrepreneurs, the foundation for new successful businesses is created. For more information visit www.innovationnorway.com.

Technology Strategy Board is the UK's innovation agency and works to create economic growth by ensuring that the UK is a global leader in innovation. Sponsored by the Department for Business, Innovation and Skills (BIS), the Technology Strategy Board brings together business, research and the public sector, supporting and accelerating the development of innovative products and services to meet market needs, tackle major societal challenges and help build the future economy. For more information please visit www.innovateuk.org.

This is a novel method that will add to the field of dermatological testing as a whole and help create more activity in extracting high value compounds from biomass. The project will last from May 2013 to March 2014 and will run from the project leader Epistem's facilities in Manchester UK and ScandiDerma's facilities in Barents Biocenter, Tromsø, Norway.

"The collaboration with ScandiDerma presents an exciting opportunity to leverage Epistem's strong scientific background in skin biology and inflammation to address the shortage of robust human dermatology models for testing inflammatory responses" said Matthew Walls, Epistem CEO. 

"For ScandiDerma this is an important milestone in building up our competence around test-systems and how to rapidly determine good lead candidates from our bioprospecting activities" noted Ingebjørg Pernille Nedal, CEO ScandiDerma.

The collaboration is made possible through the UK's innovation agency, the Technology Strategy Board, and Innovation Norway following a successful application for funding in the "Sustainable high value chemical manufacture through industrial biotechnology" competition.

(Source: Marketwire)

Associated companies:


Related news

Latest news

Visit Servogear at Seawork International in Southampton, 3-5 July 2018

You are welcome....

Use Lamiflex for faster heating cable installation

The heating floor is placed directly underneath the wooden floor,

DNV GL partners with the EU and Government of India to bring offshore wind to the Indian market

the world’s largest resource of independent energy experts...

Food safety: ISO 22000:2018 has been published

The landscape for food safety and food chains is transforming.

Celebrates 30 amazing years

After 30 years in business, AKVA group’s subsidiary Plastsveis welcomed employees, 

New Catapult Centers for us

Bergen Technology Transfer, 

HM King Harald and HM Queen Sonja visited Sørfold

Elkem Salten met Their Majesties King Harald and Queen Sonja of Norway

TechnipFMC and DOF Subsea announce the delivery of Skandi Recife and commencement of contract with Petrobras

Skandi Recife has state of the art pipelay and marine technology. 

DOF Subsea awarded FPSO hook-up contract in the Atlantic region

DOF Subsea has been awarded ...